Hong Xiao, Ph.D.

Hong Xiao


Pharmaceutical Outcomes and Policy


EMAIL: hxiao18@cop.ufl.edu

PHONE: 352-273-6711

CV: Link to CV



  • Ph.D., Pharmaceutical Socioeconomics, University of Iowa
  • B.S., Pharmacy, Peking University, China

Biographical Sketch

Hong Xiao, Ph.D., holds a doctorate degree in pharmaceutical socioeconomics from the University of Iowa and a Bachelor of Science degree in pharmacy from Peking University, formerly Beijing Medical University. She joined the UF College of Pharmacy in March 2015. Her teaching includes PharmD courses: Principles of Evidence-based Practice (EBP) and EBP-related transcending concept in several Patient Care courses. Graduate level courses include Applied Data Analysis, Interpretation and Reporting Findings in Pharmacy and a team-taught research introductory course. She serves on the College Curriculum committee and Assessment sub-committee.  Conceptually, Dr. Xiao is interested in access to, cost and utilization of health and pharmaceutical services; and patient-reported outcomes (quality of life, patient satisfaction and self-rated health status). Her research falls into >1 of the following inter-related and overlapping broad and sub-categories:

Research Interests

Broad categories:

  • Evaluation research
  • Disparity research
  • Comparative effectiveness research
  • Health services research
  • Outcomes research
  • Medical/health geography research
  • Spatial epidemiology research


  • Large database linkage and analysis – predictive analytics
  • Alternative payment model – payment innovation evaluation
  • Cost and utilization analysis
  • Treatment pattern analysis
  • Multilevel modeling
  • Spatial hotspot analysis
  • Geographically-weighted regression analysis


  • Changes in policies or practice guidelines on utilization of health services and outcomes
  • Changes in modifiable risk factors on health outcomes
  • Innovative payment models on economic burden and health outcomes
  • Social determinants (including environmental factors) on health outcomes/disparities/equity
  • Value-added pharmacist/pharmaceutical services on patient outcomes

Therapeutic areas:

  • Cancer/Oncology
  • Immunology–IBD
  • Metabolic diseases


  • International Society for Pharmacoepidemiology
  • International Society for Pharmacoeconomics and Outcomes Research
  • American Association of Colleges of Pharmacy
  • American Association for Cancer Research

Recent Publications

Xiao, H, Ali, Askal, Tan, Fei, Adunlin, Georges, and Huang, Youjie. (2017). Survival Analysis of Women with Triple Negative Breast Cancer using EMR-Linked Cancer Registry Data in Florida. J Womens Health Gyn. 1: 1-10.

Tan, F, Xiao, H, Gummadi, S, Koniaris, L, Feldman, J, Ali, A, Adunlin, G, and Huang, Y. (2017). Impact of Body Mass Index on Prognosis for Breast Cancer Patients. Journal of Women’s Health and Gynecology. 4: 1-11.

Ali, A., Xiao, H., Tawk, R., Campbell, E., Semykina, A., Montero, A. J., & Diaby, V. (2017). Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy. Current Medical Research and Opinion, Feb;33(2):391-400.

Gilbert SM, Pow-Sang JM, Xiao H. (2016) Geographical Factors Associated With Health Disparities in Prostate Cancer. Cancer Control. Oct;23(4):401-408

Xiao, H., Tan, F., Goovaerts, P., Adunlin, G., Ali, A., Huang, Y., & Clement G.K. (2016) Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida. American Journal of Men’s Health, 10(4):285-295

Ali A, Xiao H, Campbell, E and Vakaramoko D. (2015) Improving Health Care Decision Making in the USA Through Comparative Effectiveness Research: The Role of Economic Evaluation. Pharm Med DOI 10.1007/s40290-015-0113-7

Xiao, H., Tan F, Adunlin G, Ali A, Goovaerts P, Gwede C and Huang Y. (2015) Factors Associated with Overall Survival Prostate Cancer in Florida: A Multilevel Analysis. Journal of Health Care for the Poor and Underserved. 26: 266–277

Diaby V, Tawk R, Sanogo V, Xiao H and Montero A. (2015) A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer. Breast Cancer Res Treat 2015 May;151(1):27-40

Goovaerts P, Xiao H, Adunlin G, Ali A, Tan F, Gwede C and Huang Y. (2015) Geographically-weighted regression analysis of percentage of late-stage prostate cancer diagnosis in Florida. Applied Geography 62; 191-200

Adunlin, G., Diaby,V., Montero, A., & Xiao, H. (2014). Application of Multi-Criteria Decision Analysis in Health Care: A Systematic Review and Bibliometric Analysis. Health Expectations.  December ; 18(6): 1894–1905


You can find more publications on Dr. Xiao’s ResearchGate